Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.
Identifieur interne : 000007 ( PubMed/Curation ); précédent : 000006; suivant : 000008Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.
Auteurs : Fernando Ezquer [Chili] ; Jaime Gutiérrez [Chili] ; Marcelo Ezquer [Chili] ; Christian Caglevic [Chili] ; Helio C. Salgado [Brésil] ; Sebastián D. Calligaris [Chili]Source :
- Stem cell research & therapy [ 1757-6512 ] ; 2015.
Abstract
Chemotherapy has made an essential contribution to cancer treatment in recent decades despite its adverse effects. As cancer survivors have increased, concern about ex-patient lifespan has become more important too. Doxorubicin is an effective anti-neoplastic drug that produces a cardiotoxic effect. Cancer survivors who received doxorubicin became more vulnerable to cardiac disease than the normal population did. Many efforts have been made to prevent cardiac toxicity in patients with cancer. However, current therapies cannot guarantee permanent cardiac protection. One of their main limitations is that they do not promote myocardium regeneration. In this review, we summarize and discuss the promising use of mesenchymal stem cells for cardio-protection or cardio-regeneration therapies and consider their regenerative potential without leaving aside their controversial effects on tumor progression.
DOI: 10.1186/s13287-015-0109-y
PubMed: 26104315
PubMed Central: PMC4478637
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000007
Links to Exploration step
pubmed:26104315Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.</title><author><name sortKey="Ezquer, Fernando" sort="Ezquer, Fernando" uniqKey="Ezquer F" first="Fernando" last="Ezquer">Fernando Ezquer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author><author><name sortKey="Gutierrez, Jaime" sort="Gutierrez, Jaime" uniqKey="Gutierrez J" first="Jaime" last="Gutiérrez">Jaime Gutiérrez</name><affiliation wicri:level="1"><nlm:affiliation>Facultad Ciencias de la Salud, Universidad San Sebastián, Lota 2465, 1° piso Edificio A, Providencia, Santiago, 7500000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Facultad Ciencias de la Salud, Universidad San Sebastián, Lota 2465, 1° piso Edificio A, Providencia, Santiago, 7500000</wicri:regionArea></affiliation></author><author><name sortKey="Ezquer, Marcelo" sort="Ezquer, Marcelo" uniqKey="Ezquer M" first="Marcelo" last="Ezquer">Marcelo Ezquer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author><author><name sortKey="Caglevic, Christian" sort="Caglevic, Christian" uniqKey="Caglevic C" first="Christian" last="Caglevic">Christian Caglevic</name><affiliation wicri:level="1"><nlm:affiliation>Fundación Arturo Lopez Pérez, Rancagua, Providencia, Santiago, 7500000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Fundación Arturo Lopez Pérez, Rancagua, Providencia, Santiago, 7500000</wicri:regionArea></affiliation></author><author><name sortKey="Salgado, Helio C" sort="Salgado, Helio C" uniqKey="Salgado H" first="Helio C" last="Salgado">Helio C. Salgado</name><affiliation wicri:level="1"><nlm:affiliation>Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Monte Alegre, Ribeirão Preto, São Paulo, 14049-900, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Monte Alegre, Ribeirão Preto, São Paulo, 14049-900</wicri:regionArea></affiliation></author><author><name sortKey="Calligaris, Sebastian D" sort="Calligaris, Sebastian D" uniqKey="Calligaris S" first="Sebastián D" last="Calligaris">Sebastián D. Calligaris</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile. scalligaris@udd.cl.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="doi">10.1186/s13287-015-0109-y</idno><idno type="RBID">pubmed:26104315</idno><idno type="pmid">26104315</idno><idno type="pmc">PMC4478637</idno><idno type="wicri:Area/PubMed/Corpus">000007</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000007</idno><idno type="wicri:Area/PubMed/Curation">000007</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000007</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.</title><author><name sortKey="Ezquer, Fernando" sort="Ezquer, Fernando" uniqKey="Ezquer F" first="Fernando" last="Ezquer">Fernando Ezquer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author><author><name sortKey="Gutierrez, Jaime" sort="Gutierrez, Jaime" uniqKey="Gutierrez J" first="Jaime" last="Gutiérrez">Jaime Gutiérrez</name><affiliation wicri:level="1"><nlm:affiliation>Facultad Ciencias de la Salud, Universidad San Sebastián, Lota 2465, 1° piso Edificio A, Providencia, Santiago, 7500000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Facultad Ciencias de la Salud, Universidad San Sebastián, Lota 2465, 1° piso Edificio A, Providencia, Santiago, 7500000</wicri:regionArea></affiliation></author><author><name sortKey="Ezquer, Marcelo" sort="Ezquer, Marcelo" uniqKey="Ezquer M" first="Marcelo" last="Ezquer">Marcelo Ezquer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author><author><name sortKey="Caglevic, Christian" sort="Caglevic, Christian" uniqKey="Caglevic C" first="Christian" last="Caglevic">Christian Caglevic</name><affiliation wicri:level="1"><nlm:affiliation>Fundación Arturo Lopez Pérez, Rancagua, Providencia, Santiago, 7500000, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Fundación Arturo Lopez Pérez, Rancagua, Providencia, Santiago, 7500000</wicri:regionArea></affiliation></author><author><name sortKey="Salgado, Helio C" sort="Salgado, Helio C" uniqKey="Salgado H" first="Helio C" last="Salgado">Helio C. Salgado</name><affiliation wicri:level="1"><nlm:affiliation>Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Monte Alegre, Ribeirão Preto, São Paulo, 14049-900, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Monte Alegre, Ribeirão Preto, São Paulo, 14049-900</wicri:regionArea></affiliation></author><author><name sortKey="Calligaris, Sebastian D" sort="Calligaris, Sebastian D" uniqKey="Calligaris S" first="Sebastián D" last="Calligaris">Sebastián D. Calligaris</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile. scalligaris@udd.cl.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000</wicri:regionArea></affiliation></author></analytic><series><title level="j">Stem cell research & therapy</title><idno type="eISSN">1757-6512</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chemotherapy has made an essential contribution to cancer treatment in recent decades despite its adverse effects. As cancer survivors have increased, concern about ex-patient lifespan has become more important too. Doxorubicin is an effective anti-neoplastic drug that produces a cardiotoxic effect. Cancer survivors who received doxorubicin became more vulnerable to cardiac disease than the normal population did. Many efforts have been made to prevent cardiac toxicity in patients with cancer. However, current therapies cannot guarantee permanent cardiac protection. One of their main limitations is that they do not promote myocardium regeneration. In this review, we summarize and discuss the promising use of mesenchymal stem cells for cardio-protection or cardio-regeneration therapies and consider their regenerative potential without leaving aside their controversial effects on tumor progression.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="In-Process"><PMID Version="1">26104315</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>24</Day></DateCreated><DateRevised><Year>2015</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-6512</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Stem cell research & therapy</Title><ISOAbbreviation>Stem Cell Res Ther</ISOAbbreviation></Journal><ArticleTitle>Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.</ArticleTitle><Pagination><MedlinePgn>116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13287-015-0109-y</ELocationID><Abstract><AbstractText>Chemotherapy has made an essential contribution to cancer treatment in recent decades despite its adverse effects. As cancer survivors have increased, concern about ex-patient lifespan has become more important too. Doxorubicin is an effective anti-neoplastic drug that produces a cardiotoxic effect. Cancer survivors who received doxorubicin became more vulnerable to cardiac disease than the normal population did. Many efforts have been made to prevent cardiac toxicity in patients with cancer. However, current therapies cannot guarantee permanent cardiac protection. One of their main limitations is that they do not promote myocardium regeneration. In this review, we summarize and discuss the promising use of mesenchymal stem cells for cardio-protection or cardio-regeneration therapies and consider their regenerative potential without leaving aside their controversial effects on tumor progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ezquer</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutiérrez</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Facultad Ciencias de la Salud, Universidad San Sebastián, Lota 2465, 1° piso Edificio A, Providencia, Santiago, 7500000, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezquer</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caglevic</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fundación Arturo Lopez Pérez, Rancagua, Providencia, Santiago, 7500000, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado</LastName><ForeName>Helio C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Monte Alegre, Ribeirão Preto, São Paulo, 14049-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calligaris</LastName><ForeName>Sebastián D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Av. Las Condes 12348, Lo Barnechea, Santiago, 7690000, Chile. scalligaris@udd.cl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cell Res Ther</MedlineTA><NlmUniqueID>101527581</NlmUniqueID><ISSNLinking>1757-6512</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2003 Feb;63(2):368-77</RefSource><PMID Version="1">12527808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2003 Sep 19;114(6):763-76</RefSource><PMID Version="1">14505575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12929-34</RefSource><PMID Version="1">14566054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2004 Mar 23;109(11):1428-33</RefSource><PMID Version="1">15023870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2004 Oct 29;95(9):911-21</RefSource><PMID Version="1">15472116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 1983 Apr;51(7):1167-74</RefSource><PMID Version="1">6573121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1986 Mar 5;261(7):3068-74</RefSource><PMID Version="1">3005279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 1991 Dec;18(4):241-52</RefSource><PMID Version="1">1842575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 1993 Jul;27(7):1248-53</RefSource><PMID Version="1">8252585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1994 Jan;124(1-2):1-6</RefSource><PMID Version="1">8294493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 1994 Apr;45(4):649-56</RefSource><PMID Version="1">8183243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 1999 May;55(1):73-83</RefSource><PMID Version="1">10472781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Dec 1;104(12):3581-7</RefSource><PMID Version="1">15297308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biol Int. 2006 Jul;30(7):576-82</RefSource><PMID Version="1">16731012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Aug 25;126(4):663-76</RefSource><PMID Version="1">16904174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S9-S14</RefSource><PMID Version="1">17230222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Cardiovasc Dis. 2007 Mar-Apr;49(5):330-52</RefSource><PMID Version="1">17329180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2008 Jan;26(1):279-89</RefSource><PMID Version="1">17962701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Heart Fail. 2008 Mar;10(3):233-43</RefSource><PMID Version="1">18321777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2008 Aug;34(5):391-406</RefSource><PMID Version="1">18358614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2008 Oct 1;100(19):1368-79</RefSource><PMID Version="1">18812549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1956-65</RefSource><PMID Version="1">18775851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2008 Dec;17(12):1189-95</RefSource><PMID Version="1">18506671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Card Surg. 2009 Sep-Oct;24(5):591-9</RefSource><PMID Version="1">19538224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2009;339:b4606</RefSource><PMID Version="1">19996459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2010 Jan 19;121(2):276-92</RefSource><PMID Version="1">20038740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2010 Feb 9;121(5):675-83</RefSource><PMID Version="1">20100968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2010 May 7;395(3):367-72</RefSource><PMID Version="1">20382121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2010 May;16(5):203-9</RefSource><PMID Version="1">20335067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Drugs. 2010 Jul;21(6):578-90</RefSource><PMID Version="1">20375725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2010 Oct 1;107(7):913-22</RefSource><PMID Version="1">20671238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2011 Jan;29(1):11-9</RefSource><PMID Version="1">21280155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Apr 8;8(4):389-98</RefSource><PMID Version="1">21474103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2011;(9):CD008011</RefSource><PMID Version="1">21901716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2011 Nov;32(21):2634-41</RefSource><PMID Version="1">21596799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Nov 26;378(9806):1847-57</RefSource><PMID Version="1">22088800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2012 Jan 6;110(1):126-44</RefSource><PMID Version="1">22223210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytotherapy. 2012 Feb;14(2):162-72</RefSource><PMID Version="1">21954833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2012 Mar 10;379(9819):895-904</RefSource><PMID Version="1">22336189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytotherapy. 2012 Apr;14(4):412-22</RefSource><PMID Version="1">22242830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cardiol Rev. 2011 Nov;7(4):214-20</RefSource><PMID Version="1">22758622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cardiol Rev. 2011 Nov;7(4):234-44</RefSource><PMID Version="1">22758624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e40763</RefSource><PMID Version="1">22808256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Aug;13(8):790-801</RefSource><PMID Version="1">22658655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1370-81</RefSource><PMID Version="1">22952284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47559</RefSource><PMID Version="1">23133515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2013 Jan 1;22(1):37-50</RefSource><PMID Version="1">22998387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharm Pharmacol. 2013 Feb;65(2):157-70</RefSource><PMID Version="1">23278683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Basic Res Cardiol. 2013 Mar;108(2):334</RefSource><PMID Version="1">23411815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rev Port Cardiol. 2013 May;32(5):395-409</RefSource><PMID Version="1">23623503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Rev. 2013 Jun;9(3):266-80</RefSource><PMID Version="1">22350458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):310-8</RefSource><PMID Version="1">23688246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2013 Jul;72(1):127-38</RefSource><PMID Version="1">23680920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2013 Aug;8(2):603-8</RefSource><PMID Version="1">23807148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2013 Aug 30;113(6):810-34</RefSource><PMID Version="1">23989721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Physiol Biochem. 2013;32(4):1072-82</RefSource><PMID Version="1">24217648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2013 Dec;10(12):697-710</RefSource><PMID Version="1">24165948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Lett. 2014 Jan 30;224(3):380-6</RefSource><PMID Version="1">24291741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mediators Inflamm. 2013;2013:181020</RefSource><PMID Version="1">24391353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2013;13:535</RefSource><PMID Version="1">24209831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2014 Feb;387(1-2):279-85</RefSource><PMID Version="1">24257807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2014 Mar 4;63(8):809-16</RefSource><PMID Version="1">24291281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Res. 2014 Apr;163(4):307-20</RefSource><PMID Version="1">24378637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2014 Apr;13(4):962-75</RefSource><PMID Version="1">24502925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2014 Oct 1;352(2):220-7</RefSource><PMID Version="1">25016057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2014;2014:532161</RefSource><PMID Version="1">25140317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2014 Dec 1;281(2):221-9</RefSource><PMID Version="1">25448438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015;10(2):e0115686</RefSource><PMID Version="1">25671635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res Ther. 2015;6:26</RefSource><PMID Version="1">25886612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Ind Health. 2015 Jul;31(7):638-44</RefSource><PMID Version="1">23512535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2000 Apr;49(4):527-31</RefSource><PMID Version="1">10871188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Oct 27;275(43):33585-92</RefSource><PMID Version="1">10899161</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC4478637</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-015-0109-y</ArticleId><ArticleId IdType="pii">10.1186/s13287-015-0109-y</ArticleId><ArticleId IdType="pubmed">26104315</ArticleId><ArticleId IdType="pmc">PMC4478637</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Eau/explor/LotaV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000007 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000007 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Eau
|area= LotaV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26104315
|texte= Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26104315" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LotaV3
| This area was generated with Dilib version V0.6.39. |  |